NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









SonoVascular, Inc.

SonoVascular, Inc.

Private
Chapel Hill, North CarolinaHealthcare & Life Scienceshttps://sonovascular.com/

Last Round

Series A

Feb 3, 2026

Est. Valuation

$25M

Total Funding Raised

$9.31M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

SonoVascular, Inc. is a medical device company developing an ultrasound-facilitated, thrombolytic-enhanced thrombectomy system for the treatment of venous and arterial thrombosis.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical Imaging

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

thrombectomyvenous thromboembolismVTEcatheter-based thrombectomydeep vein thrombosisDVTpulmonary embolismPEsonothrombolysisultrasound-facilitated thrombectomyclot removalmedical deviceinterventional radiologyminimally invasive surgeryvascular intervention

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

SonoVascular, Inc. Comparables

Compare SonoVascular, Inc. with similar companies based on industry and business-model similarity.

SonoVascular, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Thrombolex, Inc.
92%
Caeli Vascular, Inc.
90%
Innova Vascular
88%

SonoVascular, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AFeb 3, 2026
VC RoundOct 29, 2024
DebtMay 16, 2024
DebtMar 31, 2024
Convertible DebtJun 30, 2023
Seed
Mar 31, 2022

Key People

Founding team and executive leadership

Daniel Estay

Founder CEO

Founding Team

Luke Harada

Chief Operating Officer

Executive Team

SonoVascular, Inc. Investors

Notable investors and investment history

SonoVascular, Inc. investors
InvestorRounds
North Carolina Biotechnology CenterDebt
Wolfpack Investor NetworkSeed, Convertible Debt, VC Round
Harbright VenturesVC Round, Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 24, 2026

    Monthly visitors increased 112% MoM, reaching 1K.

  • Feb 4, 2026

    Robert Ross, Founding Partner at Harbright Ventures, joins the board.

SonoVascular, Inc. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

SonoVascular, Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about SonoVascular, Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersChapel Hill, North Carolina
Employee Range11
Year Founded2018
Last FundingFeb 3, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.